Clinical Evaluation of MP4CO: A Phase 1b Escalating-Dose, Safety and Tolerability Study in Stable Adult Patients with Sickle Cell Disease.
about
Clinical Evaluation of MP4CO: A Phase 1b Escalating-Dose, Safety and Tolerability Study in Stable Adult Patients with Sickle Cell Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinical Evaluation of MP4CO: ...... ents with Sickle Cell Disease.
@en
Clinical Evaluation of MP4CO: ...... ents with Sickle Cell Disease.
@nl
type
label
Clinical Evaluation of MP4CO: ...... ents with Sickle Cell Disease.
@en
Clinical Evaluation of MP4CO: ...... ents with Sickle Cell Disease.
@nl
prefLabel
Clinical Evaluation of MP4CO: ...... ents with Sickle Cell Disease.
@en
Clinical Evaluation of MP4CO: ...... ents with Sickle Cell Disease.
@nl
P2860
P1476
Clinical Evaluation of MP4CO: ...... ents with Sickle Cell Disease.
@en
P2093
MP4CO-SCD-105 Study Investigators
Peter E Keipert
P2860
P356
10.1007/978-3-319-38810-6_3
P407
P577
2016-01-01T00:00:00Z